CBD May Help Address “Digital Era Fatigue,” Review Finds
- The review published in CNS and Neurodegenerative Targets highlights cannabidiol (CBD) as a potential therapeutic option for Digital Era Fatigue, a condition caused by excessive screen time and social media use.
- Digital Era Fatigue is characterized by cognitive tiredness, mood instability, sleep disruption, and physiological stress linked to neuroinflammation, oxidative stress, and neurotransmission changes.
- Researchers found that CBD interacts with the endocannabinoid system, serotonin 5-HT1A receptors, dopamine receptors, and PPARγ, potentially reducing neuroinflammation and oxidative stress, which may alleviate symptoms of Digital Era Fatigue.
- Although CBD shows promise for stress regulation, mood balance, and cognitive resilience, the review stresses the need for more clinical trials to assess safety, dosage, drug interactions, and combined use with digital hygiene strategies.
A review published in CNS and Neurodegenerative Targets – Discovery On Target suggests that cannabidiol (CBD) may have therapeutic potential for addressing what researchers describe as Digital Era Fatigue, a condition linked to excessive screen time and social media use.
Conducted by researchers from Amity University, the review defines Digital Era Fatigue as a neurobehavioral syndrome marked by cognitive tiredness, mood instability, sleep disruption and physiological stress stemming from chronic digital exposure. The authors note that growing evidence links the condition to neuroinflammation, oxidative stress and changes in neurotransmission.
For the review, researchers examined peer-reviewed preclinical and clinical studies from databases including PubMed, Scopus and ScienceDirect, focusing on CBD’s pharmacological mechanisms, neuroprotective effects and potential role in anxiety, sleep and cognitive regulation.
The researchers found that CBD interacts with several pathways that may be relevant to Digital Era Fatigue, including the endocannabinoid system, serotonin 5-HT1A receptors, dopamine receptors and peroxisome proliferator-activated receptor gamma (PPARγ). They also noted that CBD may help reduce neuroinflammatory and oxidative stress responses.
According to the review, these mechanisms may contribute to CBD’s anxiolytic, neuroprotective and sleep-regulating effects. Evidence from studies involving anxiety and sleep disorders suggests CBD may support stress regulation, mood balance and cognitive resilience, though the authors emphasized that direct clinical research on CBD for Digital Era Fatigue remains limited.
The review concludes that CBD shows promise as a potential “neuroadaptive” option for reducing the cognitive, emotional and physiological effects of chronic digital exposure. However, researchers cautioned that possible dose-dependent liver toxicity, drug interactions and ethical concerns—particularly when used by otherwise healthy people—mean more research is needed.
The authors called for future clinical trials using biomarkers, as well as studies combining CBD with digital hygiene strategies, to determine whether CBD can be safely and effectively used as part of an evidence-based approach to managing Digital Era Fatigue.